6523 POSTER Clinical and potential prognostic significance of serum mesothelin and osteopontin in chemotherapy treated patients affected by malignant pleural mesothelioma

M.Mencoboni; M.Serra; G.Tunesi; M.Gianola; L.Rebella; V.Galbusera; R.Filiberti; R.Puntoni; M.Paganuzzi; M.Bergaglio

首页> 外文期刊>European Journal of Cancer Supplements >6523 POSTER Clinical and potential prognostic significance of serum mesothelin and osteopontin in chemotherapy treated patients affected by malignant pleural mesothelioma

【24h】

6523 POSTER Clinical and potential prognostic significance of serum mesothelin and osteopontin in chemotherapy treated patients affected by malignant pleural mesothelioma

机译：6523 POSTER化疗治疗恶性胸膜间皮瘤患者血清间皮素和骨桥蛋白的临床及潜在预后意义

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《European Journal of Cancer Supplements》 |2007年第4期|共1页
作者
M.Mencoboni; M.Serra; G.Tunesi; M.Gianola; L.Rebella; V.Galbusera; R.Filiberti; R.Puntoni; M.Paganuzzi; M.Bergaglio;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Serum Mesothelin, Osteopontin and Vimentin: Useful Markers for Clinical Monitoring of Malignant Pleural Mesothelioma [J] . Alessandra Bonotti, Silvia Simonini, Elena Pantani, The International journal of biological markers . 2017,第1期

机译：血清间皮素，骨桥蛋白和波形蛋白：用于恶性胸膜间皮瘤临床监测的有用标志物
2. Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma [J] . Bonotti Alessandra, Simonini Silvia, Pantani Elena, The International journal of biological markers . 2017,第1期

机译：血清中学，骨桥蛋白和Vimentin：恶性胸膜间皮瘤的临床监测有用标志物
3. Clinical Response of Live-Attenuated, Listeria monocytogenes Expressing Mesothelin (CRS-207) with Chemotherapy in Patients with Malignant Pleural Mesothelioma [J] . Hassan Raffit, Alley Evan, Kindler Hedy, Clinical cancer research: an official journal of the American Association for Cancer Research . 2019,第19期

机译：患有宫廷素（CRS-207）的活衰减，患有恶性胸膜间皮瘤患者的临床响应
4. Feasibility trial assessing intrapleural photodynamic therapy combined with pleurectomy/decortication then chemotherapy in malignant pleural mesothelioma patients. [C] . Serge Mordon, Camille Munck, Ecaterina Surmei-Pintilie, International Photodynamic Association World Congress . 2019

机译：可行性试验评估腹膜内光动力学治疗与胸膜切除术/凝固患者患者在恶性胸膜间皮瘤患者中相结合。
5. An economic analysis of the addition of bevacizumab to standard chemotherapy in patients with malignant pleural mesothelioma. [D] . Malacan, Jean. 2016

机译：恶性胸膜间皮瘤患者在标准化疗中加用贝伐单抗的经济分析。
6. A serum mesothelin level is a prognostic indicator for patients with malignant mesothelioma in routine clinical practice [O] . Mark Linch, Spyridon Gennatas, Stanislav Kazikin, 2014

机译：血清间皮素水平是常规临床实践中恶性间皮瘤患者的预后指标
7. Serum mesothelin, osteopontin and vimentin: useful markers for clinical monitoring of malignant pleural mesothelioma [O] . Bonotti, Alessandra, Simonini, Silvia, Pantani, Elena, 2017

机译：血清间皮素，骨桥蛋白和波形蛋白：用于临床监测恶性胸膜间皮瘤的有用标志物

6523 POSTER Clinical and potential prognostic significance of serum mesothelin and osteopontin in chemotherapy treated patients affected by malignant pleural mesothelioma

著录项

相似文献

相关主题

期刊订阅